Targeted activation of the AMPK signaling pathway alleviates NAFLD progression through multiple mechanisms, including lipid metabolism regulation, anti-inflammatory effects, restoration of antioxidant capacity, and enhanced autophagy. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.